Friday, July 17, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 442 (OTC: $VSYM) (TSX: $KHRN.TO)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 442 (OTC: $VSYM) (TSX: $KHRN.TO)

Delta, Kelowna, BC, July 17, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public and private company announcements.

View Systems, Inc.’s (OTC: VSYMSannabis S.A.S. announced that they will meet today with students and faculty from the University of Cauca to implement their internship program established through a Collaboration Agreement # 25-32.8-010 with Sannabis’ Taller Libre Community Association. University of Cauca was founded in 1827 as the University of Popayan and later changed name to Universidad del Cauca in 1884.
For more information on the University visit, http://www.unicauca.edu.co/portaleningles/about-us

This agreement with the University allows Sannabis to approach major food and medical corporations that want to enter the cannabis space but are limited by research.
The Internship Program will cover the following areas:
  1. Research projects on the medicinal properties of Sannabis products, application of the products, protocols for product certification, dosing protocol for diseases, and research that derives from the projects of companies that support this initiative. (Health Sciences Faculty).
  2. Research projects on the benefits of cosmetic products. (Faculty of Engineering)
  3. Research projects of social impacts, in the development of community proposals, derived from the process of cultivation, transformation, commercialization and application of products.
  4. Research, production and development projects in the process of , psychoactive (THC) and non-psychoactive (CBD) cultivation, cultivation for flower, seed, stems, and comprehensive use of cannabis (Faculty of Agricultural Sciences).
  5. Cannabis regulation. (Faculty of Law, political and social sciences)

Sannabis previously announced a site visit of their Seed Propagation Facility near
Popayan-CAUCA by the Colombian Institute of Agriculture (ICA) on July 30, 2020 at 9am. ICA will inspect, make recommendations, and give the Company 60 days to comply, after which the approval process begins. Sannabis applied for this license prior to December 31, 2018, the deadline for new applications, after this date no more applications are being accepted. Arguably a Colombian Seed Use License could be the most sought after and valuable marijuana license anywhere in the World.

The University of Cauca will certify Sannabis products as well as the Sannabis Cultivars from their seed bank. Students will also study the dosification and efficacy of Sannabis products giving the Company a huge advantage over competitors.

“I don’t believe many Cannabis products on the shelves in the U.S. and elsewhere have been analyzed and certified by a 190-year-old University. Dosage has always been an issue with consumers since it’s anecdotal and until now wasn’t backed by research, right now it’s trial and error to find the dosage that works for you,” stated John Campo, President of View Systems, Inc. and Sannabis co-founder.

“We’re proud to be working with the University in my hometown,” stated Juan Paulo Guzman, co-founder and Director of Sannabis. “Several other much bigger companies were after this relationship and we’re happy the University recognized our 23 years working with the community making quality products and promoting a new livelihood,” continued Mr. Guzman.

Students will work with Sannabis’ ongoing projects focusing on Medical and Social Components of Sannabis products and other initiatives that involve the integral use of cannabis, taking into account the aforementioned and being aware of the importance of each of the academic disciplines in all processes.

Sannabis has been working in Cauca, Colombia’s top marijuana growing region for over 23 years, educating Indigenous tribes and locals on the health benefits of the legitimate use of marijuana. Cauca is home to landrace strains made famous by a documentary chronicling a futile attempt by a European seed bank to take these strains out of Colombia.

To view a timeline of Sannabis’ 23-year history in Cauca, visit https://www.tallerlibre.org/historia

NuggMD, the nation's leading medical marijuana telemedicine platform, announced that it is now providing telemedicine services to patients in Ohio for $139.
Ohio normally prohibits the use of telemedicine for medical marijuana evaluations, but has lifted this restriction for the duration of the pandemic emergency orders. This makes it possible for patients to get their MMJ recommendation without risking exposure to Sars-COV-2.

"We're so excited to join Ohio's medical marijuana community," says Alex Milligan, NuggMD Co-Founder and CMO. "We hope that Ohio will see the benefit of allowing medical marijuana telemedicine services to continue for the long term. Even after the pandemic is over, and we don't know how long this will take, telemedicine is an incredibly valuable tool for at-risk patients."

"COVID-19 is forcing the medical community to re-consider their long-standing prejudices against telemedicine," says Kam Babazade, NuggMD Co-Founder and COO. "The misperception that patients can't receive the same quality of care and follow up via telemedicine has forced immunocompromised patients to risk exposure to illness in order to comply with local state laws. After the pandemic is over, these patients will face the same unnecessary risks to their health. We hope the state will consider making this change to their policy permanent for the well-being of at-risk cannabis patients across the state."

The state has not yet determined when the emergency orders for COVID-19 will be lifted. Recently, several states have seen a resurgence of the virus and have taken measures to increase social distancing again.

At the time this press release was written, Ohio had 46,970 confirmed cases of COVID-19, 7,681 hospitalizations and 2,807 total deaths. This total reflects a spike in confirmed cases over the final weekend of June. Those at the highest risk of contracting the virus are advised by authorities to remain at home as much as possible.

An Ohio medical marijuana evaluation with NuggMD costs just $139. As always, patients who are not approved for a medical marijuana recommendation receive their evaluation for free.

Since 2016, NuggMD has helped more than 600,000 patients connect face-to-face with their MMJ doctors via video telemedicine in California, New York, Nevada, Oklahoma and Missouri. NuggMD's practitioners provide medical marijuana recommendations to patients only in states for which they are fully-licensed to practice medicine. They are also approved to provide recommendations by their respective regulatory agencies where necessary.

Tidal Health Solutions Ltd., a privately held Licensed Producer (LP) and one of Canada's leading suppliers of Cannabis 2.0 products, announced that it is now supplying topical cannabis products in Canada.

"Our topical products are the result of extensive research and development and are leading the category in Canada", said Mark E. Burton, President and CEO of Tidal Health Solutions. "We are one of the few Licensed Producers providing these products".

Tidal's RIVA brand focuses on the benefits of cannabidiol (CBD) while the TULLIA brand features equal amounts of CBD and tetrahydrocannabinol (THC). Both come in 200mg and 400mg cannabinoids per jar formats. They are both fast absorbing lotions with a natural eucalyptus extract that provide a pleasant cooling sensation similar to a cool ocean breeze.
"In my clinical experience, well-developed topicals may be useful for conditions close to the skin's surface such as arthritis and neuropathic pain", said Dr. Douglas Smith, a founder of Tidal Health Solutions and a national expert in the medical use of cannabis. "They are very pleasant and easy to use".

The products are now available in Ontario, New Brunswick, Nova Scotia, Saskatchewan and will soon be available in Prince Edward Island and Alberta.

Khiron Life Sciences Corp.  (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and Director will lead a live, on-camera virtual tour of the Company's recently completed 15,000 square foot Zerenia integrated medical facility located in Bogota, Colombia.

Date: Tuesday, July 21st
Tour start: 9:00am ET
Participants: Alvaro Torres, Khiron CEO and Director, together with popular Colombia broadcaster Jorge Hernan Pelaez

This will be the first in a series of live, interactive events present by Khiron. Attendees are invited to ask the Company questions in real time, learn about the clinic operational model, meet members of the medical team, and discuss the Zerenia health and wellbeing advantages, including operations during the Covid-19 recovery. An archived recording will be available after the event.

Recent Company Highlights:
       Becomes the first and, to date, only company fully authorized to manufacture and sell high-THC medical cannabis for patient prescriptions in Colombia
       Signs distribution deal for its Kuida™ CBD cosmeceutical brand with Red Yellow Red, a leading EU distributor of cosmetic products, bringing the Kuida brand to the Spanish market
       Enters into an agreement with Nimbus Health, a leading German distributor of medical cannabis products to bring Khiron branded EU GMP medical cannabis to Germany
       Receives first medical cannabis prescriptions for patients participating in the UK's Project Twenty21, Europe's largest study of the effectiveness and tolerability of medical cannabis


Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.


Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  




Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Wednesday, July 15, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 441 (TSX: $AVCN.TO) (CSE: $IMCC.C) (OTC: $PSYC)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 441 (TSX: $AVCN.TO) (CSE: $IMCC.C) (OTC: $PSYC)


Delta, Kelowna, BC, July 15, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public and private company announcements.

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announced that its Rho Phyto™ product line of advanced medical cannabis products will be the subject of a Medical Cannabis Real-World Evidence study ("MC-RWE Study") led by Dr. Hance Clarke of the University Health Network ("UHN") in Toronto, Canada. The Rho Phyto products were developed in accordance with the recent Health Canada Cannabis 2.0 regulations that allow for more advanced, higher quality, medical cannabis product offerings. These products have been tested for prolonged stability, enhanced absorption, controlled delivery and other properties, in collaboration with Dr. Christine Allen's research group at the Leslie Dan Faculty of Pharmacy, University of Toronto.

The Rho Phyto medical cannabis product line is a full formulary that includes sublingual sprays, oil drops, capsules, and topicals of various cannabinoid ratios, namely THC and CBD.
By offering a variety of delivery systems, the medical community has the possibility to select the appropriate Rho Phyto product to suit a range of medical conditions such as pain relief, which may require either a fast onset of action or prolonged duration of effect over the course of treatment. The products are manufactured under good manufacturing practice ("GMP") in partnership with MediPharm Labs Inc. to ensure batch-to-batch consistency and high-quality products. The manufacture of the Rho Phyto products in accordance with GMP standard allows for data derived from this MC-RWE Study to provide early insights into Avicanna's ongoing and future directions of pharmaceutical development. Avicanna remains committed to patient safety and product consistency which is why all products subject to the MC-RWE Study are tested by Sigma Analytical and tracked by TruTrace Blockchain Technologies.

Dr. Justin Grant, Avicanna's Executive Vice President of Scientific Affairs commented, "After 3 years of collaborating with world-class Toronto-based researchers and clinicians including those at the University of Toronto and UHN, we are excited to offer the most consistent formulary of advanced medical cannabis products to prescribers and principal investigators, including Dr. Clarke, to further demonstrate the potential therapeutic efficacy of cannabinoids."
Avicanna's Rho Phyto products will be exclusively available to patients through the Medical

Cannabis by Shoppers online portal in addition to UHN clinicians through the MC-RWE Study by the end of July 2020. Additionally, Avicanna and Medical Cannabis by Shoppers are co-hosting a medical symposium in line with the launch of the Rho Phyto product line entitled, "MEDICAL CANNABIS 2.0: Advancements in Cannabinoid Research, Product Offerings and Patient Access". The symposium will be held on a virtual platform on July 21, 2020 and will include Dr Clarke's presentation "Real World Evidence and The Future of Medical Cannabis / Cannabinoid medicine for Pain Management" that will provide further insights on the MC-RWE Study. For registration and more information please visit (https://www.avicanna.com/symposium/).

The Health Depot Pharmacy and Lyte Medical announced their patient-centered online partnership; a venture that will help Canadians access medical care and prescriptions from the comfort and safety of their homes.

As Canadians adjust to a new reality and work to establish new daily routines; consistent access to healthcare and medications takes on even more importance. Virtual and direct-to-door prescription delivery are a necessity in meeting patients where they are.

According to the Canadian Radiotelevision and Telecommunications Commission, nationally, 86% of Canadian households have access to high speed internet. This online access presents health care practitioners and pharmacists with an opportunity to connect with patients remotely and remove some of the barriers to continuity of care including wait times, transportation, and scheduling.

In February 2020, The Canadian Medical Association, the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada released a report on the future of virtual care in Canada. They emphasized the importance of prioritizing quality-based virtual care that truly respects the needs of Canadians.

"As a registered pharmacist since 2011, I have witnessed the evolution of health care in Canada. The Health Depot Pharmacy's partnership with Lyte Medical will allow Ontarians to see a physician and access their prescribed medications in a timely fashion", says Andy Donald, Founder & CEO of The Health Depot Pharmacy. "Our unique pharmacy services and approach allows necessary medications to be delivered promptly to those who rely on them, wherever and whenever they need them."

The Health Depot makes the pharmacy and healthcare shopping experience simple for all Ontarians. Their healthcare e-commerce store has thousands of health essentials available for online purchase and delivery, which can be shipped together with prescriptions for free.

Their Daily Dose Packs allow for an easy approach for patients who are taking multiple medications to have a simple, one daily packet approach, which is particularly helpful to seniors, caregivers, chronically ill, and individuals with special needs among others.

"Our forward thinking partnership with The Health Depot Pharmacy creates unprecedented access to a seamless virtual care experience. Canadians need medical care and medications in ways that accommodate their life circumstances", Ali Mohamed, CEO of Lyte Medical says. "Lyte Medical's virtual platform allows patients to speak to a doctor from the comfort of their own home and obtain their prescribed medications and health products online from The Health Depot Pharmacy, next day for free anywhere in Ontario with direct to door delivery."

Lyte Medical's patient friendly website makes connecting with a physician simple and easy. Lyte's comprehensive services include primary care, specialist referrals, mental health support, chronic pain treatment, and acute care. Patients will no longer have to take a day off from work, make childcare arrangements, or wait in line for their prescriptions, and for those living in rural areas, or vacationing at the cottage, The Health Depot and Lyte Medical will bring healthcare to Canadians at home, wherever that may be.

IM Cannabis Corp. (CSE: IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, announced that its German subsidiary, Adjupharm GmbH, has received a definitive purchase commitment of medical cannabis over the next twelve months from Zur Rose Pharma GmbH, an established distributor in Germany. This is the Company's fourth definitive purchase commitment with a distributor in Germany and advances IMC's strategy of creating a network of distribution partnerships to maximize penetration of IMC-branded products.

"We have now signed our fourth sales agreement with a binding purchase commitment. More importantly, we have added Zur Rose Pharma GmbH as a key partner, a well-established and reputable pharmaceutical service provider and  wholesaler that bolsters our ability to provide quality medical cannabis products across the large and dynamic German market. As we continue to add trusted partners to our MCO network, we firmly believe that we have created a strong foundation to become the preeminent brand in international medical cannabis," said Oren Shuster, CEO of IMC.

"The momentum IMC has established within the German market is indicative of strong demand and favourable industry fundamentals for medical cannabis. With the launch of the IMC brand in Germany in Q3 2020, we have been deploying our sales teams to further physician education across the country and build our brand's reputation as a reliable provider of top quality medical cannabis to patients, pharmacists and physicians," added Richard Balla, CEO of Adjupharm.


Through its EU-GMP certified subsidiary, Adjupharm, the Company has entered into a three-year sales agreement with the medical cannabis distributor Zur Rose Pharma GmbH in Germany. This distributor has entered into a purchase commitment under its sales agreement.

IMC has also previously announced that Focus Medical Herbs Ltd. has signed six binding sales agreements for the distribution of IMC-branded medical cannabis products in Israel. Total consolidated revenue from all binding sales agreements in Israel is expected to be $193.5 million with an expected gross margin of 50%. A total of 33,075kg of medical cannabis will be delivered in Israel between Q2 2020 and 2023, and 3,000kg of medical cannabis under the sales agreements is expected to reach pharmacies in 2020.

Global Trac Solutions, Inc. (OTC: PSYCannounced the 2nd monthly release and distribution of the July edition of its Microdose Monthly newsletter, which features three articles that provide an overview of Kevin O’Leary’s investment participation with MindMed, a review of Gwyneth Paltrow’s Goop Lab on Netflix, and an exclusive one-on-one interview with Chi Psilocybin, a prominent voice for the psychedelic reform movement and owner of Truffles Therapy in Amsterdam.

The interview with Chi, amply titled “A Servant of the Mushroom Kingdom,” is an in-depth look at a personal journey and discovery of the benefits associated with a life-long affinity for psychedelics and finding life’s passion and purpose. On a trip to Thailand, Chi met his future wife and co-founder of their company, Truffles Therapy, a psilocybin retreat that has become his life’s work and has hosted many hundreds of “journeyers” from all over the world. Chi believes that everyone should have the opportunity to experience the magic of mushrooms.

David Flores, Global CEO, said, “I would like to personally thank Chi for taking the time to share his unique and fascinating story with us and for the voice he lends to the psychedelic reform movement taking place across the globe. Chi is playing a vital role in the industry’s continued emergence into society’s mainstream, which is showing great promise through clinical studies for treating debilitating mental health conditions, in addition to improving quality of life for millions across the globe. I believe that our subscribers are really going to enjoy this month’s latest newsletter written by Mr. Kent Sligh, Global’s Creative Content Director. Furthermore, I look forward to developing our network of industry leaders and advocates and exploring opportunities throughout this process to establish some of the strategic partnerships that will in time contribute to our emergence as an industry leader for news and information.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  




Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Tuesday, July 14, 2020

SinglePoint (OTCQB: $SING) Shares Insights and Highlights Related to Its Investment in Jacksam Corporation, a High Growth Automation Company Serving CBD and Cannabis Businesses @_Singlepoint_

SinglePoint (OTCQB: $SING) Shares Insights and Highlights Related to Its Investment in Jacksam Corporation, a High Growth Automation Company Serving CBD and Cannabis Businesses @_Singlepoint_

Phoenix, Arizona - July 14, 2020 (Investorideas.com Newswire) SinglePoint, Inc. (OTCQB: SING) shares recent corporate update by the Convectium/Jacksam Corporation CEO, Mark Adams. The Convectium/Jacksam Presentation by CEO Mark Adams originally aired via webcast on June 25, 2020 and was produced by Torrey Hills Capital.


Cannot view this video? Visit: https://www.youtube.com/watch?v=vh2x_HOzlds

Jacksam Corporation ("Convectium"), an automation solutions company providing machines and equipment to legalized and licensed CBD and THC companies, have signed a memorandum of understanding to create an exclusive proprietary cartridge and POD pre-racking solution, allowing producers and extractors to scale to meet rapidly increasing demand.


SinglePoint's senior management were invited to view the live webcast. Post viewing SinglePoint initiated subsequent discussion and communications with Jacksam to explore whether there are additional opportunities to strengthen the relationship between the two companies.

Mark Adams outlined three desired outcomes as a result of Convectium Jacksam realigning its business strategy to focus on selling high margin machines, offering pre-rack solutions and expanding its strategic partnerships.

Profitability: The Company anticipates being cash flow positive by the 3rd Quarter of this year.

Increasing Scalability by focusing on leading multi-state operators
Streamline Offerings to align with current strategic partners to increase future cash flow, margins and operating leverage



The company highlighted that its gross margin improved from 21% in 2019 to 53% in the first quarter of 2020 as a result of the new business model. Jacksam expects these margins to continue to rise, crossing over 60% as the recurring revenue royalty agreements begin to contribute to the bottom line in the back half of the year. The addressable market according to company management is estimated to be (cartridges, filling and capping equipment) approximately $500M growing at 18.4% annually (potentially higher with US legalization).

"I was impressed by the thoroughness of the and the directness and insight provided by Mark Adams, CEO of Jacksam as he systematically outlined and discussed their current operations and near term growth strategy and after viewing I felt that the shareholders of SinglePoint, who own about 6.8% of Jacksam, should have the opportunity to view the presentation as well," stated Wil Ralston, President SinglePoint.

In March 2017, the Company issued 4,878,049 shares of common stock and cash to acquire a 10% investment stake of Jacksam Corporation. Jacksam/Convectium subsequently merged with a publicly traded entity in November 2018. Since the Merger, Jacksam's primary business has been the design, manufacturing and sale of vaporizer cartridge filling machines, capping machines, and cartridges to customers in the medical and recreational cannabis, hemp, and CBD industries.

"We were originally attracted and compelled to make an investment into Jacksam/Convectium based upon the belief that they had developed industry leading, patentable technologies and solutions that could disrupt traditional manual inefficiencies with an automated process that would significantly increase the accuracy, speed and profitability of its clients," said Greg Lambrecht, CEO SinglePoint. "As evidenced by the compelling overview provided by the current CEO Mark Adams, Jacksam/Convectium has pivoted and evolved its business plan and is executing against its strategic plan and has the opportunity to increase its revenues and attain profitability by the end of the year by continuing to leverage and expand its relationships with the premier partners such as Jupiter Research, ATG Pharma and 14th Round in their respective industries. The combination of continued relentless execution, vision and leadership can make this a leading technology company in the segment of the vaporizer cartridge filling, capping, and automation systems, which should result in them increasing their current market share and value thereby increasing the value of the investment for SinglePoint and its shareholders.
This investment has the potential to be a true win-win for Jacksam and more importantly the over 20,000 SinglePoint shareholders."

As reported in Jacksam Corporation's Form 10-K For the Fiscal Year Ended December 31, 2019 SinglePoint is listed as a beneficial owner (known shareholders of record owning more than 5% of our common stock). The percentage of shares beneficially owned was computed as of December 31, 2019, on the basis of 62,871,972 shares of common stock outstanding. The historical 52 Week Range is $0.1000 - $1.1500. The Market Cap as of 7/12/2020 is just over $12,000,000.



About Convectium
Convectium Jacksam Corporation designs, manufactures and sells automation equipment for cannabis and CBD oil producers. Offering the only UL certified filling and capping machines specifically designed for the cannabis industry, Convectium machines work with nearly any commercially available cartridge, POD, vape or other inhalation device. As a first mover in large-scale post-extraction technology, Convectium holds numerous global patents and serves the most prestigious cannabis and CBD companies in the world. For more information, visit https://get.convectium.com/

About SinglePoint, Inc.
Founded in 2011 SinglePoint, Inc (SING) invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand.

Connect on social media at:
For more information visit: www.SinglePoint.com

Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Corporate Communication
SinglePoint Inc.
888-OTC-SING
investors@SinglePoint.com
SinglePoint.com

SinglePoint (SING) is a featured stock on Investorideas.com

More info on SING at Investorideas.com Visit: https://www.investorideas.com/CO/SING/


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. For Disclosure purposes SinglePoint Inc (OTCQB: SING) is a paid  annual news and social media company on Investorideas.com.  More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp and https://www.investorideas.com/About/News/Clientspecifics.asp . Learn more about our prices for publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories